Peer Review History
| Original SubmissionOctober 6, 2020 |
|---|
|
PONE-D-20-31348 Invasive species allelopathy decreases plant growth and soil microbial activity PLOS ONE Dear Dr. Qu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript has been reviewed by two referees that raised a series of critical comments. Please prepare a revised version addressing all these comments. Please submit your revised manuscript by Dec 18 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Raffaella Balestrini Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 3. Please amend your list of authors on the manuscript to ensure that each author is linked to an affiliation. Authors’ affiliations should reflect the institution where the work was done (if authors moved subsequently, you can also list the new affiliation stating “current affiliation:….” as necessary). [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The aim of the work is to demonstrate the allelopathic effect of the plant Rhus typhina on Tagetes erecta and soil microbial population. Authors use a water extract from R. typhina roots. The extract was obtained after grinding the dried roots, incubating the root powder in water for 48 h under shaking, concentrating the extract in a rotary evaporator and freeze drying. The extract was then used to prepare solutions at different concentrations. Solutions were used to water pots containing plants. All the following analyses (plant growth, soil properties, microbial community diversity) were done on soil and plants sampled from these pots. The work is well described; however, I have a big concern about the pertinence of using the root extract. Author should explain how this root extract added to the soil can mimic what R. typhina is really releasing in the soil during its growth. In fact, the extract contains the molecules that water could extract from the whole root, but there is no proof that those molecules are the ones that R. typhina roots exudate in the soil. In the introduction, authors cite the “novel weapon hypothesis” and say that “Our results support the ‘novel weapons hypothesis’”. The cited hypothesis is proposed by Callaway and Ridenour (2004) who say “that some exotics transform from native weaklings to invasive bullies by exuding biochemicals that are highly inhibitory (allelopathic) to plants or soil microbes in invaded communities”. The hypothesis is based on molecules released as exudates. Also, the cited works in the discussion are about root exudates, rhizospheric soil, leaf leachates. Authors describe the effects on T. erecta growth and on soil bacteria, but those effect are due to molecules extracted from roots non exudated by roots. There is a big difference between root exudates and root extract. Also, the choice of the control is not convincing. In my opinion, a more appropriate control would be not water but root extract from a plant that do not have an allelopathic effect on T. erecta, like one historically living in the same habitat. Authors should be sure that the effect on soil microbial activity is due specifically to R. typhina molecules and not to a general shift in microbial population due to the addition to the soil of any root extract. In some points of the discussion authors over-interpret their data: lines 202-203: they state “Taken together, our results indicate how allelopathy impacts both plant and soil community, revealing that plant–soil microbe interactions can mediate invasion success”. I agree on the first part on the sentence, since root extract do have an effect on plant growth and on microbial population. However, data do not help us understanding whether the effect on plant is direct or mediated by microbes. Line 204: “our results show that plants have the potential to alter soil”: this sentence is misleading: written like this means that plants, in their active growth, can alter soil, but results are on root extract not on exudates. Lines 206-207. “This study suggests that invasive species can increase their own fitness relative to other plant species by modifying soil conditions and microbial community” and Lines 238-239 “are the main factors shifting soil microbial activity and mediating the impact of invasive plants on the growth of other plants.” Again, there is not proof in the work that effect on plants is either direct or mediated by other factors. Citation of literature is sometimes not appropriate Line 209: Tian et al 2017: this work is about the effect of N fertilisation on soil microbial community, not on allelopathy Lines 226-228: “These results are partially in agreement with previous studies indicating that root extracts serve as soil carbon substrates for specific soil microbial communities (Fan et al. 2010, Wu et al. 2013, Li et al. 2017)”. None of these cited papers deal about root extracts: they describe works on exudates and rhizospheric soil. Minor points Line 41: either remove “is”, or add “which” before “is” Line 64: Substitute “As” with “It is” or rephrase the sentence Line 98: “five plant” modify in “five plants” Line 137: remove “in” Line 138: change “concentration extracts” to “extract concentrations” Lines 146-147: according to Table 1, plant height is not significantly different from control at 10 mg/mL. Line 164: table 2 shows soil properties data not AWCD. Line 230: Olchowik et al. 2012 demonstrated the presence of tannins in leaves: there is no indication of their presence in roots Reviewer #2: The manuscript Invasive species allelopathy decreases plant growth and soil microbial activity aims at demonstrating the capaicty of the invasive shurb R. typhina to inihibit other plants growth to invade the soil. Data reported support the hypothesis that R. typhina roots extracts inhibited T. erecta growth via altering the physico-chemical soil conditions, as well as the microbial community. The manuscript is well written and presented in intellegible fashion. Beside I am not English mother-tongue, it seems that the manuscript has been written in standard English. The conclusion are supported by the reported data. However more information on the conditions in which T. erecta has been grown during the experimental condition,such as light humidity, temperature, photoperiod. More information about the use Community-level physiological profiles (CLPP) should be provided for reader who are not familiar with such method. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Biancaelena Maserti [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Invasive species allelopathy decreases plant growth and soil microbial activity PONE-D-20-31348R1 Dear Dr. Qu, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Raffaella Balestrini Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Authors took in consideration all my concerns and replied accordingly. Minor points lines 25 and 209: change "in particularly" with "in particular" Reviewer #2: The authors responded to all my previous comments and now the manuscript could be published. I reccomen to change to lower case, the initial character of roots at line 22: roots, instead Roots. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Biancaelena Maserti |
| Formally Accepted |
|
PONE-D-20-31348R1 Invasive species allelopathy decreases plant growth and soil microbial activity Dear Dr. Qu: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr Raffaella Balestrini Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .